Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00749255 · ClinicalTrials.gov registry record
Collect Breast Cancer Patients' Digital Mammography Images With Corresponding Reports for the Development of Software
A clinical trial, sponsored by WellSpan Health.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00749255: Clinical Trial study, sponsored by WellSpan Health.
NCT00749255 is a clinical trial that was terminated before completion, run by WellSpan Health. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00749255 was terminated before completion, sponsored by WellSpan Health.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this case collection effort is software design by R2 Technologies, Inc., The information received from Women's Imaging will be provided to the Case Collection, Data Management and Algorithm/software design and development teams who are responsible for the receipt of patient data and management of such data; and creation, testing and validation of R2 Technologies, Inc., for Computer Aided Detection (CAD) and new digital image archiving software design.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-01 |
Why NCT00749255 stopped before completion
NCT00749255 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00749255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00749255 about?
NCT00749255 is a clinical study titled "Collect Breast Cancer Patients' Digital Mammography Images With Corresponding Reports for the Development of Software". The purpose of this case collection effort is software design by R2 Technologies, Inc., The information received from Women's Imaging will be provided to the Case Collection, Data Management and Algorithm/software design and development teams who are responsible for the receipt of patient data and m...
What is the current status of trial NCT00749255?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2008-05. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT00749255?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia